Global Opioid-Induced Constipation Market Growth 2023-2028

Report ID: 1161854 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Opioid-Induced Constipation Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Opioid-Induced Constipation by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Opioid-Induced Constipation by Country/Region, 2017, 2022 & 2028
    2.2 Opioid-Induced Constipation Segment by Type
        2.2.1 Methylnaltrexone Bromide
        2.2.2 Lubiprostone
        2.2.3 Naloxegol
        2.2.4 Others
    2.3 Opioid-Induced Constipation Sales by Type
        2.3.1 Global Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
        2.3.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Opioid-Induced Constipation Sale Price by Type (2017-2022)
    2.4 Opioid-Induced Constipation Segment by Application
        2.4.1 Hospital
        2.4.2 Pharmacy
        2.4.3 Other
    2.5 Opioid-Induced Constipation Sales by Application
        2.5.1 Global Opioid-Induced Constipation Sale Market Share by Application (2017-2022)
        2.5.2 Global Opioid-Induced Constipation Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Opioid-Induced Constipation Sale Price by Application (2017-2022)
3 Global Opioid-Induced Constipation by Company
    3.1 Global Opioid-Induced Constipation Breakdown Data by Company
        3.1.1 Global Opioid-Induced Constipation Annual Sales by Company (2020-2022)
        3.1.2 Global Opioid-Induced Constipation Sales Market Share by Company (2020-2022)
    3.2 Global Opioid-Induced Constipation Annual Revenue by Company (2020-2022)
        3.2.1 Global Opioid-Induced Constipation Revenue by Company (2020-2022)
        3.2.2 Global Opioid-Induced Constipation Revenue Market Share by Company (2020-2022)
    3.3 Global Opioid-Induced Constipation Sale Price by Company
    3.4 Key Manufacturers Opioid-Induced Constipation Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Opioid-Induced Constipation Product Location Distribution
        3.4.2 Players Opioid-Induced Constipation Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Opioid-Induced Constipation by Geographic Region
    4.1 World Historic Opioid-Induced Constipation Market Size by Geographic Region (2017-2022)
        4.1.1 Global Opioid-Induced Constipation Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Opioid-Induced Constipation Annual Revenue by Geographic Region
    4.2 World Historic Opioid-Induced Constipation Market Size by Country/Region (2017-2022)
        4.2.1 Global Opioid-Induced Constipation Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Opioid-Induced Constipation Annual Revenue by Country/Region
    4.3 Americas Opioid-Induced Constipation Sales Growth
    4.4 APAC Opioid-Induced Constipation Sales Growth
    4.5 Europe Opioid-Induced Constipation Sales Growth
    4.6 Middle East & Africa Opioid-Induced Constipation Sales Growth
5 Americas
    5.1 Americas Opioid-Induced Constipation Sales by Country
        5.1.1 Americas Opioid-Induced Constipation Sales by Country (2017-2022)
        5.1.2 Americas Opioid-Induced Constipation Revenue by Country (2017-2022)
    5.2 Americas Opioid-Induced Constipation Sales by Type
    5.3 Americas Opioid-Induced Constipation Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Opioid-Induced Constipation Sales by Region
        6.1.1 APAC Opioid-Induced Constipation Sales by Region (2017-2022)
        6.1.2 APAC Opioid-Induced Constipation Revenue by Region (2017-2022)
    6.2 APAC Opioid-Induced Constipation Sales by Type
    6.3 APAC Opioid-Induced Constipation Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Opioid-Induced Constipation by Country
        7.1.1 Europe Opioid-Induced Constipation Sales by Country (2017-2022)
        7.1.2 Europe Opioid-Induced Constipation Revenue by Country (2017-2022)
    7.2 Europe Opioid-Induced Constipation Sales by Type
    7.3 Europe Opioid-Induced Constipation Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Opioid-Induced Constipation by Country
        8.1.1 Middle East & Africa Opioid-Induced Constipation Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Opioid-Induced Constipation Revenue by Country (2017-2022)
    8.2 Middle East & Africa Opioid-Induced Constipation Sales by Type
    8.3 Middle East & Africa Opioid-Induced Constipation Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Opioid-Induced Constipation
    10.3 Manufacturing Process Analysis of Opioid-Induced Constipation
    10.4 Industry Chain Structure of Opioid-Induced Constipation
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Opioid-Induced Constipation Distributors
    11.3 Opioid-Induced Constipation Customer
12 World Forecast Review for Opioid-Induced Constipation by Geographic Region
    12.1 Global Opioid-Induced Constipation Market Size Forecast by Region
        12.1.1 Global Opioid-Induced Constipation Forecast by Region (2023-2028)
        12.1.2 Global Opioid-Induced Constipation Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Opioid-Induced Constipation Forecast by Type
    12.7 Global Opioid-Induced Constipation Forecast by Application
13 Key Players Analysis
    13.1 Takeda Pharmaceuticals
        13.1.1 Takeda Pharmaceuticals Company Information
        13.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Offered
        13.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Takeda Pharmaceuticals Main Business Overview
        13.1.5 Takeda Pharmaceuticals Latest Developments
    13.2 Bayer
        13.2.1 Bayer Company Information
        13.2.2 Bayer Opioid-Induced Constipation Product Offered
        13.2.3 Bayer Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Bayer Main Business Overview
        13.2.5 Bayer Latest Developments
    13.3 Sanofi
        13.3.1 Sanofi Company Information
        13.3.2 Sanofi Opioid-Induced Constipation Product Offered
        13.3.3 Sanofi Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sanofi Main Business Overview
        13.3.5 Sanofi Latest Developments
    13.4 Mallinckrodt
        13.4.1 Mallinckrodt Company Information
        13.4.2 Mallinckrodt Opioid-Induced Constipation Product Offered
        13.4.3 Mallinckrodt Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Mallinckrodt Main Business Overview
        13.4.5 Mallinckrodt Latest Developments
    13.5 Salix (Bausch Health)
        13.5.1 Salix (Bausch Health) Company Information
        13.5.2 Salix (Bausch Health) Opioid-Induced Constipation Product Offered
        13.5.3 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Salix (Bausch Health) Main Business Overview
        13.5.5 Salix (Bausch Health) Latest Developments
    13.6 AstraZeneca
        13.6.1 AstraZeneca Company Information
        13.6.2 AstraZeneca Opioid-Induced Constipation Product Offered
        13.6.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 AstraZeneca Main Business Overview
        13.6.5 AstraZeneca Latest Developments
    13.7 Progenics Pharmaceuticals
        13.7.1 Progenics Pharmaceuticals Company Information
        13.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Offered
        13.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Progenics Pharmaceuticals Main Business Overview
        13.7.5 Progenics Pharmaceuticals Latest Developments
    13.8 Purdue Pharm
        13.8.1 Purdue Pharm Company Information
        13.8.2 Purdue Pharm Opioid-Induced Constipation Product Offered
        13.8.3 Purdue Pharm Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Purdue Pharm Main Business Overview
        13.8.5 Purdue Pharm Latest Developments
    13.9 Nektar Therapeutics
        13.9.1 Nektar Therapeutics Company Information
        13.9.2 Nektar Therapeutics Opioid-Induced Constipation Product Offered
        13.9.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Nektar Therapeutics Main Business Overview
        13.9.5 Nektar Therapeutics Latest Developments
    13.10 Daiichi Sankyo
        13.10.1 Daiichi Sankyo Company Information
        13.10.2 Daiichi Sankyo Opioid-Induced Constipation Product Offered
        13.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Daiichi Sankyo Main Business Overview
        13.10.5 Daiichi Sankyo Latest Developments
    13.11 Prestige
        13.11.1 Prestige Company Information
        13.11.2 Prestige Opioid-Induced Constipation Product Offered
        13.11.3 Prestige Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Prestige Main Business Overview
        13.11.5 Prestige Latest Developments
    13.12 GSK
        13.12.1 GSK Company Information
        13.12.2 GSK Opioid-Induced Constipation Product Offered
        13.12.3 GSK Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 GSK Main Business Overview
        13.12.5 GSK Latest Developments
    13.13 Shionogi
        13.13.1 Shionogi Company Information
        13.13.2 Shionogi Opioid-Induced Constipation Product Offered
        13.13.3 Shionogi Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Shionogi Main Business Overview
        13.13.5 Shionogi Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Opioid-Induced Constipation Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Opioid-Induced Constipation Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Methylnaltrexone Bromide
    Table 4. Major Players of Lubiprostone
    Table 5. Major Players of Naloxegol
    Table 6. Major Players of Others
    Table 7. Global Opioid-Induced Constipation Sales by Type (2017-2022) & (K Units)
    Table 8. Global Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
    Table 9. Global Opioid-Induced Constipation Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Opioid-Induced Constipation Revenue Market Share by Type (2017-2022)
    Table 11. Global Opioid-Induced Constipation Sale Price by Type (2017-2022) & (USD/Unit)
    Table 12. Global Opioid-Induced Constipation Sales by Application (2017-2022) & (K Units)
    Table 13. Global Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Table 14. Global Opioid-Induced Constipation Revenue by Application (2017-2022)
    Table 15. Global Opioid-Induced Constipation Revenue Market Share by Application (2017-2022)
    Table 16. Global Opioid-Induced Constipation Sale Price by Application (2017-2022) & (USD/Unit)
    Table 17. Global Opioid-Induced Constipation Sales by Company (2020-2022) & (K Units)
    Table 18. Global Opioid-Induced Constipation Sales Market Share by Company (2020-2022)
    Table 19. Global Opioid-Induced Constipation Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Opioid-Induced Constipation Revenue Market Share by Company (2020-2022)
    Table 21. Global Opioid-Induced Constipation Sale Price by Company (2020-2022) & (USD/Unit)
    Table 22. Key Manufacturers Opioid-Induced Constipation Producing Area Distribution and Sales Area
    Table 23. Players Opioid-Induced Constipation Products Offered
    Table 24. Opioid-Induced Constipation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Opioid-Induced Constipation Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Opioid-Induced Constipation Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Opioid-Induced Constipation Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Opioid-Induced Constipation Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Opioid-Induced Constipation Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Opioid-Induced Constipation Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Opioid-Induced Constipation Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Opioid-Induced Constipation Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Opioid-Induced Constipation Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Opioid-Induced Constipation Sales Market Share by Country (2017-2022)
    Table 37. Americas Opioid-Induced Constipation Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Opioid-Induced Constipation Revenue Market Share by Country (2017-2022)
    Table 39. Americas Opioid-Induced Constipation Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
    Table 41. Americas Opioid-Induced Constipation Sales by Application (2017-2022) & (K Units)
    Table 42. Americas Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Table 43. APAC Opioid-Induced Constipation Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Opioid-Induced Constipation Sales Market Share by Region (2017-2022)
    Table 45. APAC Opioid-Induced Constipation Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Opioid-Induced Constipation Revenue Market Share by Region (2017-2022)
    Table 47. APAC Opioid-Induced Constipation Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
    Table 49. APAC Opioid-Induced Constipation Sales by Application (2017-2022) & (K Units)
    Table 50. APAC Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Table 51. Europe Opioid-Induced Constipation Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Opioid-Induced Constipation Sales Market Share by Country (2017-2022)
    Table 53. Europe Opioid-Induced Constipation Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Opioid-Induced Constipation Revenue Market Share by Country (2017-2022)
    Table 55. Europe Opioid-Induced Constipation Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
    Table 57. Europe Opioid-Induced Constipation Sales by Application (2017-2022) & (K Units)
    Table 58. Europe Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Opioid-Induced Constipation Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Opioid-Induced Constipation Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Opioid-Induced Constipation Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Opioid-Induced Constipation Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Opioid-Induced Constipation Sales by Application (2017-2022) & (K Units)
    Table 66. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Opioid-Induced Constipation
    Table 68. Key Market Challenges & Risks of Opioid-Induced Constipation
    Table 69. Key Industry Trends of Opioid-Induced Constipation
    Table 70. Opioid-Induced Constipation Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Opioid-Induced Constipation Distributors List
    Table 73. Opioid-Induced Constipation Customer List
    Table 74. Global Opioid-Induced Constipation Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Opioid-Induced Constipation Sales Market Forecast by Region
    Table 76. Global Opioid-Induced Constipation Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Opioid-Induced Constipation Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Opioid-Induced Constipation Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Opioid-Induced Constipation Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Opioid-Induced Constipation Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Opioid-Induced Constipation Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Opioid-Induced Constipation Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Opioid-Induced Constipation Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Opioid-Induced Constipation Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Opioid-Induced Constipation Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Opioid-Induced Constipation Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Opioid-Induced Constipation Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Opioid-Induced Constipation Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Opioid-Induced Constipation Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Opioid-Induced Constipation Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Opioid-Induced Constipation Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Opioid-Induced Constipation Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Opioid-Induced Constipation Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Takeda Pharmaceuticals Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 95. Takeda Pharmaceuticals Opioid-Induced Constipation Product Offered
    Table 96. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 97. Takeda Pharmaceuticals Main Business
    Table 98. Takeda Pharmaceuticals Latest Developments
    Table 99. Bayer Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 100. Bayer Opioid-Induced Constipation Product Offered
    Table 101. Bayer Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 102. Bayer Main Business
    Table 103. Bayer Latest Developments
    Table 104. Sanofi Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 105. Sanofi Opioid-Induced Constipation Product Offered
    Table 106. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 107. Sanofi Main Business
    Table 108. Sanofi Latest Developments
    Table 109. Mallinckrodt Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 110. Mallinckrodt Opioid-Induced Constipation Product Offered
    Table 111. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 112. Mallinckrodt Main Business
    Table 113. Mallinckrodt Latest Developments
    Table 114. Salix (Bausch Health) Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 115. Salix (Bausch Health) Opioid-Induced Constipation Product Offered
    Table 116. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 117. Salix (Bausch Health) Main Business
    Table 118. Salix (Bausch Health) Latest Developments
    Table 119. AstraZeneca Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 120. AstraZeneca Opioid-Induced Constipation Product Offered
    Table 121. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 122. AstraZeneca Main Business
    Table 123. AstraZeneca Latest Developments
    Table 124. Progenics Pharmaceuticals Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 125. Progenics Pharmaceuticals Opioid-Induced Constipation Product Offered
    Table 126. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 127. Progenics Pharmaceuticals Main Business
    Table 128. Progenics Pharmaceuticals Latest Developments
    Table 129. Purdue Pharm Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 130. Purdue Pharm Opioid-Induced Constipation Product Offered
    Table 131. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 132. Purdue Pharm Main Business
    Table 133. Purdue Pharm Latest Developments
    Table 134. Nektar Therapeutics Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 135. Nektar Therapeutics Opioid-Induced Constipation Product Offered
    Table 136. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 137. Nektar Therapeutics Main Business
    Table 138. Nektar Therapeutics Latest Developments
    Table 139. Daiichi Sankyo Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 140. Daiichi Sankyo Opioid-Induced Constipation Product Offered
    Table 141. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 142. Daiichi Sankyo Main Business
    Table 143. Daiichi Sankyo Latest Developments
    Table 144. Prestige Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 145. Prestige Opioid-Induced Constipation Product Offered
    Table 146. Prestige Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 147. Prestige Main Business
    Table 148. Prestige Latest Developments
    Table 149. GSK Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 150. GSK Opioid-Induced Constipation Product Offered
    Table 151. GSK Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 152. GSK Main Business
    Table 153. GSK Latest Developments
    Table 154. Shionogi Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
    Table 155. Shionogi Opioid-Induced Constipation Product Offered
    Table 156. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 157. Shionogi Main Business
    Table 158. Shionogi Latest Developments
List of Figures
    Figure 1. Picture of Opioid-Induced Constipation
    Figure 2. Opioid-Induced Constipation Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Opioid-Induced Constipation Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Opioid-Induced Constipation Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Opioid-Induced Constipation Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Methylnaltrexone Bromide
    Figure 10. Product Picture of Lubiprostone
    Figure 11. Product Picture of Naloxegol
    Figure 12. Product Picture of Others
    Figure 13. Global Opioid-Induced Constipation Sales Market Share by Type in 2021
    Figure 14. Global Opioid-Induced Constipation Revenue Market Share by Type (2017-2022)
    Figure 15. Opioid-Induced Constipation Consumed in Hospital
    Figure 16. Global Opioid-Induced Constipation Market: Hospital (2017-2022) & (K Units)
    Figure 17. Opioid-Induced Constipation Consumed in Pharmacy
    Figure 18. Global Opioid-Induced Constipation Market: Pharmacy (2017-2022) & (K Units)
    Figure 19. Opioid-Induced Constipation Consumed in Other
    Figure 20. Global Opioid-Induced Constipation Market: Other (2017-2022) & (K Units)
    Figure 21. Global Opioid-Induced Constipation Sales Market Share by Application (2017-2022)
    Figure 22. Global Opioid-Induced Constipation Revenue Market Share by Application in 2021
    Figure 23. Opioid-Induced Constipation Revenue Market by Company in 2021 ($ Million)
    Figure 24. Global Opioid-Induced Constipation Revenue Market Share by Company in 2021
    Figure 25. Global Opioid-Induced Constipation Sales Market Share by Geographic Region (2017-2022)
    Figure 26. Global Opioid-Induced Constipation Revenue Market Share by Geographic Region in 2021
    Figure 27. Global Opioid-Induced Constipation Sales Market Share by Region (2017-2022)
    Figure 28. Global Opioid-Induced Constipation Revenue Market Share by Country/Region in 2021
    Figure 29. Americas Opioid-Induced Constipation Sales 2017-2022 (K Units)
    Figure 30. Americas Opioid-Induced Constipation Revenue 2017-2022 ($ Millions)
    Figure 31. APAC Opioid-Induced Constipation Sales 2017-2022 (K Units)
    Figure 32. APAC Opioid-Induced Constipation Revenue 2017-2022 ($ Millions)
    Figure 33. Europe Opioid-Induced Constipation Sales 2017-2022 (K Units)
    Figure 34. Europe Opioid-Induced Constipation Revenue 2017-2022 ($ Millions)
    Figure 35. Middle East & Africa Opioid-Induced Constipation Sales 2017-2022 (K Units)
    Figure 36. Middle East & Africa Opioid-Induced Constipation Revenue 2017-2022 ($ Millions)
    Figure 37. Americas Opioid-Induced Constipation Sales Market Share by Country in 2021
    Figure 38. Americas Opioid-Induced Constipation Revenue Market Share by Country in 2021
    Figure 39. United States Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Canada Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Mexico Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Brazil Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 43. APAC Opioid-Induced Constipation Sales Market Share by Region in 2021
    Figure 44. APAC Opioid-Induced Constipation Revenue Market Share by Regions in 2021
    Figure 45. China Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Japan Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 47. South Korea Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Southeast Asia Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 49. India Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Australia Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Europe Opioid-Induced Constipation Sales Market Share by Country in 2021
    Figure 52. Europe Opioid-Induced Constipation Revenue Market Share by Country in 2021
    Figure 53. Germany Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 54. France Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 55. UK Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Italy Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Russia Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Country in 2021
    Figure 59. Middle East & Africa Opioid-Induced Constipation Revenue Market Share by Country in 2021
    Figure 60. Egypt Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 61. South Africa Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Israel Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Turkey Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 64. GCC Country Opioid-Induced Constipation Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Manufacturing Cost Structure Analysis of Opioid-Induced Constipation in 2021
    Figure 66. Manufacturing Process Analysis of Opioid-Induced Constipation
    Figure 67. Industry Chain Structure of Opioid-Induced Constipation
    Figure 68. Channels of Distribution
    Figure 69. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Opioid-Induced Constipation Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Opioid-Induced Constipation Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Opioid-Induced Constipation Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports